GnuBio Unveils Sequencer at Consumer Genetics Conference, Reports Zero Error Rate in Internal Tests | GenomeWeb

At the Consumer Genetics Conference last week in Boston, GnuBio unveiled its $50,000 desktop sequencer, which recently shipped to the first of the company's beta testers ahead of a wider commercial launch of the system expected next year.

GnuBio CEO John Boyce announced at the opening of the conference that a planned live demonstration of the instrument had been cancelled due to issues with conference site regulators concerning the use of live biologic materials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.